FDA Approves Merck’s Antiretroviral Raltegravir
Merck on Friday announced that FDA has approved its antiretroviral drug raltegravir for use by HIV-positive people who have not responded to other treatments, the Wall Street Journal reports (Corbett Dooren, Wall Street Journal, 10/12). An independent FDA panel of medical experts last month unanimously recommended accelerated approval of raltegravir, an integrase inhibitor. [click link for full article]
Recent Comments